Pyrinide 500 Tablet contains Pyrazinamide 500 mg, a first-line anti-tubercular agent used to treat active tuberculosis infections. It works by inhibiting mycobacterial fatty acid synthesis, effectively reducing bacterial growth and supporting combination therapy regimens.
Pyrazinamide is primarily used during the initial intensive phase of TB treatment along with Isoniazid, Rifampicin, and Ethambutol. Its role is critical in shortening treatment duration and ensuring effective bacterial eradication.
Belonging to the anti-infective and pulmonology segment, Pyrinide 500 Tablet is in high demand among hospitals, clinics, and government TB programs. Its consistent prescription trend makes it a valuable B2B product.
For PCD pharma franchise partners, third-party manufacturers, and exporters, Pyrinide 500 Tablet provides a profitable business opportunity. Its inclusion in standard TB therapy ensures recurring demand and a strong market presence across India.
Common side effects may include nausea, vomiting, loss of appetite, and mild joint pains. Rarely, it may cause liver toxicity, gout, or allergic skin reactions. Contact your doctor immediately if you experience yellowing of eyes or skin, severe fatigue, or swelling.
Pyrinide 500 Tablet is indicated for the treatment of active tuberculosis, usually in combination with other first-line anti-TB medications such as Isoniazid and Rifampicin. It helps in reducing bacterial load and preventing disease progression.
Take Pyrinide 500 Tablet exactly as prescribed, preferably on an empty stomach. Avoid alcohol while on treatment due to risk of liver damage. Regular monitoring of liver function and uric acid levels is recommended. Do not discontinue therapy without consulting your healthcare provider.
Store Pyrinide 500 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.